Colon cancer (adjuvant) - capecitabine and oxaliplatin
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer
Summary
Capecitabine and oxaliplatin are recommended as possible adjuvant treatments after surgery for stage III (Dukes’ C) colon cancer, when used in the following ways: capecitabine on its own oxaliplatin together with 5-fluorouracil and folinic acid. The choice of treatment should be decided join ...
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in June 2009
About this guidance
Technology appraisals TA100
Issued: April 2006
How this guidance was produced
